Home » Topics » Regulatory

Regulatory
RSS

Enbrel becomes the first FDA-approved biologic for ankylosing spondylitis

July 28, 2003

Zyvox approved for diabetic foot infections

July 28, 2003

Sweden is the first to approve transplant drug Certican

July 25, 2003

Manufacturing approval granted for pitavastatin

July 23, 2003

New European label for Pegasys reflects new genotype data

July 22, 2003

New low doses of Premarin approved for prevention of postmenopausal osteoporosis

July 21, 2003

Keppra oral solution approved for epilepsy

July 21, 2003

BMS and Otsuka submit sNDA for Abilify

July 18, 2003

FDA approves Zyprexa combination for acute manic episodes

July 18, 2003

United Therapeutics files IND for i.v. Remodulin

July 15, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for July 22, 2025.
Coinfections and diversity paint the many shades of HIV cure
BioWorld
We all look different to HIV, a virus that destroys the immune system. The defensive cells record every interaction with foreign agents, infections from viruses...
Livzon’s IL-17A/F meets phase III endpoints in plaque psoriasis
BioWorld
Livzon Mabpharm Inc.’s anti-IL-17A/F monoclonal antibody, LZM-012, met the primary endpoint in a phase III trial in moderate to severe plaque psoriasis. Conducted...
Sino to acquire Lanova and pipeline for up to $950M
BioWorld Asia
Sino Biopharmaceutical Ltd. agreed to fully acquire Lanova Medicines Ltd. by buying an additional 95.09% stake in Lanova at a valuation of up to $950.92 million....